৳ 45/unit
Pack: ৳ 540
৳ 45/unit
Pack: ৳ 540
At a glance
Sucroferric Oxyhydroxide is a phosphate binder used for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis.
Indications
- Hyperphosphatemia in chronic kidney disease patients on dialysis
Pharmacology
Sucroferric Oxyhydroxide binds to phosphate in the aqueous environment of the GI tract through ligand exchange between hydroxyl groups and/or water and dietary phosphate. The bound phosphate is eliminated with feces, reducing dietary phosphate absorption and lowering serum phosphorus and calcium-phosphorus product levels.
Dosage
Adult Dose (Oral):
- Starting: 3 tablets (1500 mg) per day (1 tablet with each meal)
- Dose titration: Adjust by 500 mg (1 tablet) per day based on serum phosphorus levels
- Maximum: 6 tablets (3000 mg) per day
Side effects
Common Side Effects:
- Discolored feces (12%)
- Diarrhea (6%)
Use in pregnancy
Use in Pregnancy: No adequate controlled studies; animal studies showed post-implantation loss; use only if clearly needed; consult your doctor.
Pregnancy Category: C — always consult a doctor before taking during pregnancy.
Precautions & warnings
- Monitor patients with peritonitis, significant gastric/hepatic disorders, major GI surgery history, hemochromatosis, or iron accumulation diseases
- Caution in pregnancy and lactation
Overdose effects
No overdose data available; excessive doses may cause iron accumulation; consult your doctor.
Storage conditions
Store below 25°C; keep away from light and moisture; keep out of reach of children.